SCHEMBL14973295

SCHEMBL14973295

CCOC(=O)c1cnn(C)c1COc1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.52
RAB9A P51151 4/20 0.52
HPGD P15428 3/20 0.52
TP53 P04637 2/20 0.52
ALDH1A1 P00352 3/20 0.44
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGS2 P35354 2/20 0.42
MAPT P10636 5/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
RECQL P46063 1/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
KDM4E B2RXH2 1/20 0.42
CASP1 P29466 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14973084 0.85 HCRTR2 (0.45) NPC1RAB9AHPGDTP53ALDH1A1
SCHEMBL14973188 0.84 TSHR (0.52) NPC1RAB9AHPGDTP53ALDH1A1
SCHEMBL14973136 0.82 ALDH1A1 (0.45) NPC1RAB9AHPGDALDH1A1TSHR
SCHEMBL14973126 0.78 MAPT (0.57) NPC1RAB9AHPGDALDH1A1MAPT
SCHEMBL14973274 0.77 SMN1; SMN2 (0.52) NPC1RAB9AHPGDALDH1A1KMT2A
SCHEMBL14973272 0.77 ALDH1A1 (0.49) RAB9AHPGDTP53ALDH1A1TSHR
SCHEMBL25310219 0.76 ALDH1A1 (0.52) NPC1RAB9AHPGDALDH1A1TSHR
SCHEMBL16229739 0.76 RAB9A (0.48) NPC1RAB9AHPGDALDH1A1TSHR
SCHEMBL14973111 0.76 PAX8 (0.47) NPC1RAB9AHPGDALDH1A1KMT2A
SCHEMBL14973187 0.75 RAB9A (0.47) NPC1RAB9AHPGDALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A NPC1 964/4885RAB9A 1090/4885HPGD 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.